Stefanie Flohr, Novartis Institutes for Biomedical Research (NIBR); Anna Schubart, Novartis Institutes for Biomedical Research (NIBR)
| Start Date | 20.09.2017 - 17:00 |
| Event End | 20.09.2017 - 18:00 |
| Location | Universität Basel, Pharmazentrum |
Discovery of highly potent, selective and orally bioavailable complement alternative pathway inhibitors